“‘The Science Bridge’ initiative with its ‘Twin Institutes’ concept is a unique approach that aims to bring people of different nations and cultures together for trust building and improving human relations. With science as our common language, we will focus on brain research to find medical treatments for age-related memory dysfunction. Understanding brain functions will also help to drive innovative developments in information technology and artificial intelligence. We live in a multinational and multicultural world, where our interdependent on one another is critically needed. With ‘The Science Bridge’, we have here a great opportunity to be the first one to chart the course for the well-being of humanity.”
Karoly Nikolich is a Consulting Professor at Stanford University and a former executive director of their Neuroscience Institute. He has worked in the biotechnology industry for over 25 years. He was the founder, CEO and Chief Science Officer of AGY Therapeutics Inc. and CEO of Amnestix Inc., a biopharmaceutical company focused on developing treatments for central nervous system diseases, particularly cognitive disorders. He also served as vice president of research at Lynx Therapeutics, Inc. From 1983 to 1995, Karoly worked at Genentech Inc., where he initiated and directed neuroscience research. Since January of 2011, he is a CEO of Circuit Therapeutics, California. He is a graduate of Eotvos University in Budapest, and completed a postdoctoral fellowship at Tulane University as well as a visiting scholarship at the University of California, San Francisco.